Back to MetLife Investment Management, LLC MetLife Investment Management, LLC

MCRBMCRB

Showing 0 of 15 quarters

Position history for MetLife Investment Management, LLCMetLife Investment Management, LLC's holdings in Seres Therapeutics, Inc.

No. MetLife Investment Management exited its MCRB (Seres Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 51,439 shares worth $122,425. MetLife Investment Management first reported MCRB in Q2 2020 and held it in 14 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used